远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00512 远大医药

交易中 04-19 11:56:09

3.910

-0.020

-0.51%

最高3.940	最低3.860	成交量112.25万
今开3.910	昨收3.930	日振幅2.04%
总市值138.79亿	流通市值138.79亿	总股本35.50亿
成交额437.77万	换手率0.03%	流通股本35.50亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"远大医药","latestPrice":3.91,"timestamp":1713498712554,"preClose":3.93,"halted":0,"volume":1122500,"delay":0,"floatShares":3549571148,"shares":3549571148,"eps":0.535954,"marketStatus":"交易中","marketStatusCode":2,"change":-0.02,"latestTime":"04-19 11:56:09","open":3.91,"high":3.94,"low":3.86,"amount":4377745,"amplitude":0.020356,"askPrice":3.92,"askSize":3500,"bidPrice":3.91,"bidSize":64500,"shortable":3,"etf":0,"ttmEps":0.535954,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1713499200000},"adr":0,"listingDate":819302400000,"adjPreClose":3.93,"dividendRate":0.066496,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.176203,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512","defaultTab":"news","newsList":[{"id":"2428395878","title":"远大医药04月17日主力资金流出125万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428395878","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428395878?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:15","pubTimestamp":1713341728,"startTime":"0","endTime":"0","summary":"04月17日, 远大医药股价跌0.25%，报收3.96元，成交金额630万元，换手率0.04%，振幅1.76%，量比0.60。远大医药今日主力资金净流出125万元，连续5日净流出，上一交易日主力净流出207万元，今日环比减少39.61%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为33.33%，平均跌幅为0.98%。该股近5个交易日下跌2.94%，主力资金累计净流出489万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入347万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171615418b2df6c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171615418b2df6c4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427593025","title":"远大医药04月15日主力资金流出49万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427593025","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427593025?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:16","pubTimestamp":1713168970,"startTime":"0","endTime":"0","summary":"04月15日, 远大医药股价跌2.68%，报收3.99元，成交金额948万元，换手率0.07%，振幅2.93%，量比0.80。远大医药今日主力资金净流出49万元，连续3日净流出，上一交易日主力净流出69万元，今日环比减少28.99%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为64.29%，平均跌幅为1.37%。该股近5个交易日下跌0.50%，主力资金累计净流入364万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入684万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161634877e8e80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161634877e8e80&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427948030","title":"南向资金4月12日净买入远大医药167.40万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427948030","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427948030?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:31","pubTimestamp":1713144669,"startTime":"0","endTime":"0","summary":"4月12日, 南向资金增持远大医药167.40万股，连续3日增持。截止当日收盘，港股通共持有远大医药30236.36万股，占流通股8.51%。远大医药近5个交易日上涨6.77%，港股通累计增持181.10万股；近20个交易日上涨12.64%，港股通累计增持466.00万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415094430877cfbb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415094430877cfbb1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426827430","title":"远大医药(00512)获执行董事、行政总裁周超增持10.10万股 每股作价约3.95港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426827430","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426827430?lang=zh_cn&edition=full","pubTime":"2024-04-10 15:08","pubTimestamp":1712732918,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月8日，远大医药(00512)获执行董事、行政总裁周超增持10.10万股，每股作价3.9550港元，总金额为39.9455万港元。增持后最新持股数目26.30万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100505.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425304641","title":"远大医药盘中异动 大幅下跌5.16%报3.861港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425304641","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425304641?lang=zh_cn&edition=full","pubTime":"2024-04-05 11:34","pubTimestamp":1712288053,"startTime":"0","endTime":"0","summary":"2024年04月05日临近午盘11时34分，远大医药股票出现波动，股价快速下跌5.16%。截至发稿，该股报3.861港元/股，成交量61万股，换手率0.02%，振幅4.42%。资金方面，该股资金流入65.634万港元，流出164.53万港元。远大医药股票所在的药品行业中，整体跌幅为0.32%。其相关个股中，前海健康、三爱健康集团、天大药业涨幅较大，振幅较大的相关个股有三爱健康集团、康龙化成、复星医药，振幅分别为16.22%、9.71%、8.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405113413861e3829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405113413861e3829&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425301095","title":"远大医药(00512)下跌5.16%，报3.86元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425301095","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425301095?lang=zh_cn&edition=full","pubTime":"2024-04-05 11:34","pubTimestamp":1712288053,"startTime":"0","endTime":"0","summary":"4月5日，远大医药(00512)盘中下跌5.16%，截至11:34，报3.86元/股，成交240.02万元。远大医药集团有限公司是一家专注于抗肿瘤、心血管急救制剂、高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科及生物健康产品和精品原料药的科技创新型国际化医药企业。公司在全球范围内布局了四个技术研发平台和五个研发中心，致力于成为一家受医生和患者尊重并还原于社会的科技创新型国际化医药企业。截至2023年年报，远大医药营业总收入95.42亿元、净利润17.04亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/05113440129246.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422158021","title":"远大医药03月28日主力资金流入15万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2422158021","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422158021?lang=zh_cn&edition=full","pubTime":"2024-03-28 16:16","pubTimestamp":1711613762,"startTime":"0","endTime":"0","summary":"03月28日, 远大医药股价跌2.38%，报收4.11元，成交金额1085万元，换手率0.07%，振幅4.28%，量比0.41。远大医药今日主力资金净流入15万元，连续3日净流入，上一交易日主力净流入386万元，今日环比减少96.11%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为40.00%，平均涨幅为2.10%。该股近5个交易日上涨1.23%，主力资金累计净流入497万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1556万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032816163687bfb9e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032816163687bfb9e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422968584","title":"远大医药(00512)布局全球创新眼科药物TP-03，或将填补国内蠕形螨睑缘炎治疗市场空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2422968584","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422968584?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:31","pubTimestamp":1711531875,"startTime":"0","endTime":"0","summary":"据悉，TP-03已于2023年7月获得美国FDA批准上市，是目前FDA批准的首款也是唯一一款针对蠕形螨睑缘炎的药物。TP-03或填补国内市场空白，惠及千万蠕形螨睑缘炎患者据悉，睑缘炎是一种常见的眼科疾病。因此，临床上急需一款起效快且可直接作用于病灶深部的安全有效的治疗药物，而远大医药此次布局的TP-03则有望填补这部分临床空白，为蠕形螨睑缘炎患者带来新的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093423.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422683809","title":"远大医药(00512)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2422683809","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422683809?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:30","pubTimestamp":1711531853,"startTime":"0","endTime":"0","summary":"此外，TP-03在美国开展的用于治疗蠕形螨导致的睑板腺功能障碍的II期临床研究也显示出了阳性的顶线结果。本次交易完成后，集团将大力推进TP-03在中国的注册落地工作，尽早惠及广大蠕形螨睑缘炎患者。据统计，目前中国有超过4000万蠕形螨睑缘炎患者和超过7000万睑板腺功能障碍患者，患者人群庞大。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093417.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422968840","title":"远大医药(00512.HK)取得创新眼用制剂 “TP-03”大中华区独家授权 首付款1,500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422968840","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422968840?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:22","pubTimestamp":1711531320,"startTime":"0","endTime":"0","summary":"远大医药(00512.HK) 宣布，与联拓生物科技和Tarsus Pharmaceuticals, Inc.达成产品引进战略合作协议，在相关条件获得满足后，集团将以1,500万美元的首付款，以及一定金额的注册里程碑费用为代价，取得全球创新眼用制剂“TP-03”，在大中华区的独家开发、生产及商业化权益。集团表示，在交易完成后，将大力推进TP-03在中国的注册落地工作。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-27 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190311162624473_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190311162624473_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337748/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422331664","title":"远大医药(00512)将于6月27日派发末期股息每股0.26港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422331664","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422331664?lang=zh_cn&edition=full","pubTime":"2024-03-26 18:05","pubTimestamp":1711447547,"startTime":"0","endTime":"0","summary":"远大医药(00512)发布公告，该公司将于2024年6月27日派发截至2023年1...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092451.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422634070","title":"港股异动 | 远大医药(00512)最高涨超7% 放射性核素偶联药物国内III期临床获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2422634070","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422634070?lang=zh_cn&edition=full","pubTime":"2024-03-26 13:44","pubTimestamp":1711431898,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，远大医药最高涨超7%，截至发稿，涨6.58%，报4.21港元，成交额2122.16万港元。消息面上，近日，远大医药用于治疗胃肠胰腺神经内分泌瘤的全球创新放射性核素偶联药物 ITM-11已获得国家药监局批准开展III期临床研究。据悉，COMPOSE研究拟在中国、美国、英国、法国、德国、澳大利亚等全球11个国家入组至少202名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092191.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422638810","title":"港股异动 | 远大医药(00512)再涨超5% 治疗胃肠胰腺神经内分泌肿瘤新药获批III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2422638810","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422638810?lang=zh_cn&edition=full","pubTime":"2024-03-26 11:46","pubTimestamp":1711424771,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，远大医药早盘再涨超5%，绩后累涨约15%。截至发稿，涨5.06%，报4.15港元，成交额825.81万港元。消息面上，远大医药公布，集团用于治疗胃肠胰腺神经内分泌肿瘤的全球创新放射性核素偶联药物ITM-11，近日已获得中国国家药品监督管理局批准开展III期临床研究。董事会建议每股派息26港仙，总计分红约9.1亿港元，已连续分红6年，累计分红约28亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261148148b63a59a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261148148b63a59a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422638867","title":"远大医药盘中异动 临近午盘大幅上涨5.06%报4.151港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422638867","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422638867?lang=zh_cn&edition=full","pubTime":"2024-03-26 11:39","pubTimestamp":1711424379,"startTime":"0","endTime":"0","summary":"2024年03月26日临近午盘11时39分，远大医药股票出现波动，股价急速拉升5.06%。截至发稿，该股报4.151港元/股，成交量188.55万股，换手率0.05%，振幅3.80%。资金方面，该股资金流入365.289万港元，流出289.177万港元。远大医药股票所在的药品行业中，整体涨幅为0.03%。其相关个股中，华控康泰、远大医药、联邦制药涨幅较大，振幅较大的相关个股有天大药业、中智药业、三爱健康集团，振幅分别为7.55%、7.26%、6.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326113939861e121c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326113939861e121c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422638128","title":"远大医药(00512)股价上升5.063%，现价港币$4.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2422638128","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422638128?lang=zh_cn&edition=full","pubTime":"2024-03-26 11:39","pubTimestamp":1711424340,"startTime":"0","endTime":"0","summary":"[上升股]远大医药(00512) 股价在上午11:39比前收市价上升5.063%，现股价为港币$4.15。至目前为止，今日最高价为$4.15，而最低价为$3.99。总成交量为189.75万股，总成交金额为港币$769.44万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403261111/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422567858","title":"远大医药03月25日遭主力抛售369万元 环比增加367.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422567858","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422567858?lang=zh_cn&edition=full","pubTime":"2024-03-25 16:16","pubTimestamp":1711354600,"startTime":"0","endTime":"0","summary":"03月25日, 远大医药股价跌2.47%，报收3.95元，成交金额1529万元，换手率0.11%，振幅2.96%，量比0.62。远大医药今日主力资金净流出369万元，上一交易日主力净流出79万元，今日环比增加367.09%。该股近5个交易日上涨8.22%，主力资金累计净流入510万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入518万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032516172587b21eca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032516172587b21eca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422582130","title":"远大医药(00512.HK)治疗胃肠胰腺神经内分泌肿瘤新药获批内地三期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2422582130","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422582130?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:59","pubTimestamp":1711328340,"startTime":"0","endTime":"0","summary":"远大医药(00512.HK) 公布，集团用于治疗胃肠胰腺神经内分泌肿瘤的全球创新放射性核素偶联药物(RDC)ITM-11，近日已获得中国国家药品监督管理局批准开展三期临床研究。集团指，研究拟在中国、美国、英国、法国、德国、澳洲等全球11个国家入组至少202名患者。(ek/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-22 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190311162624473_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190311162624473_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336371/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2421322590","title":"远大医药全球创新核药ITM-11国内III期临床获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2421322590","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2421322590?lang=zh_cn&edition=full","pubTime":"2024-03-24 19:29","pubTimestamp":1711279780,"startTime":"0","endTime":"0","summary":"【远大医药全球创新核药ITM-11国内III期临床获批】远大医药公布，其创新药ITM-11近日已获得国家药监局批准开展III期临床研究（COMPOSE研究）。这是一款基于放射性核素偶联技术靶向杀伤治疗胃肠胰腺神经内分泌瘤(GEP-NETs)的创新RDC药物。COMPOSE研究是一项国际多中心的III期临床研究，拟在中国、美国、英国、法国、德国、澳大利亚等全球11个国家入组至少202名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403243022082658.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403243022082658.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421297043","title":"远大医药(00512)全球创新放射性核素偶联药物 ITM-11 在中国获批开展 III 期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2421297043","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2421297043?lang=zh_cn&edition=full","pubTime":"2024-03-24 18:50","pubTimestamp":1711277428,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 公布，该集团用于治疗胃肠胰腺神经内分泌瘤的全球创新放射性核素偶联药物 ITM-11，近日已获得中华人民共和国国家药品监督管理局批准开展 III 期临床研究。根据 Frost & Sullivan 的数据，2020 年，中国胃肠胰腺神经内分泌瘤的新发确诊病例为 71,300 例，发病率逐年上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091129.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":-0.053},{"period":"1month","weight":0.0886},{"period":"3month","weight":0.1165},{"period":"6month","weight":-0.0175},{"period":"1year","weight":-0.1732},{"period":"ytd","weight":-0.0391}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.482759,"avgChangeRate":0.094346},{"month":2,"riseRate":0.689655,"avgChangeRate":0.105408},{"month":3,"riseRate":0.37931,"avgChangeRate":0.012932},{"month":4,"riseRate":0.586207,"avgChangeRate":0.014969},{"month":5,"riseRate":0.428571,"avgChangeRate":0.068711},{"month":6,"riseRate":0.357143,"avgChangeRate":-0.049881},{"month":7,"riseRate":0.392857,"avgChangeRate":-0.01429},{"month":8,"riseRate":0.392857,"avgChangeRate":0.004418},{"month":9,"riseRate":0.464286,"avgChangeRate":-0.045547},{"month":10,"riseRate":0.535714,"avgChangeRate":-0.01036},{"month":11,"riseRate":0.535714,"avgChangeRate":0.091557},{"month":12,"riseRate":0.5,"avgChangeRate":-0.008312}],"exchange":"SEHK","name":"远大医药","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"远大医药,00512,远大医药股票,远大医药股票老虎,远大医药股票老虎国际,远大医药行情,远大医药股票行情,远大医药股价,远大医药股市,远大医药股票价格,远大医药股票交易,远大医药股票购买,远大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}